LEADER 01033oam 2200325zu 450 001 996217144303316 005 20210807003442.0 035 $a(CKB)111026746729552 035 $a(SSID)ssj0000454705 035 $a(PQKBManifestationID)12147490 035 $a(PQKBTitleCode)TC0000454705 035 $a(PQKBWorkID)10398079 035 $a(PQKB)11181074 035 $a(EXLCZ)99111026746729552 100 $a20160829d2000 uy 101 0 $aeng 181 $ctxt 182 $cc 183 $acr 200 10$a2000 2nd International Conference on Transparent Optical Networks 210 31$a[Place of publication not identified]$cI E E E$d2000 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-7803-6337-X 676 $a621.382/7 712 02$aIEEE, Institute of Electrical and Electronics Engineers, Inc. Staff 801 0$bPQKB 906 $aPROCEEDING 912 $a996217144303316 996 $a2000 2nd International Conference on Transparent Optical Networks$92511764 997 $aUNISA LEADER 03108nam 2200625Ia 450 001 9911019464703321 005 20200520144314.0 010 $a9786611069636 010 $a9781281069634 010 $a1281069639 010 $a9780470692523 010 $a0470692529 010 $a9780470766040 010 $a0470766042 035 $a(CKB)1000000000414459 035 $a(EBL)320041 035 $a(SSID)ssj0000104115 035 $a(PQKBManifestationID)11131010 035 $a(PQKBTitleCode)TC0000104115 035 $a(PQKBWorkID)10078522 035 $a(PQKB)11293551 035 $a(MiAaPQ)EBC320041 035 $a(OCoLC)232611652 035 $a(Perlego)2750955 035 $a(EXLCZ)991000000000414459 100 $a20070607d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAntiarrhythmic drugs $ea practical guide /$fRichard N. Fogoros 205 $a2nd ed. 210 $aOxford $cBlackwell Futura$d2007 215 $a1 online resource (194 p.) 300 $aPrevious ed.: New York: Blackwell Science, 1997. 311 08$a9781405163514 311 08$a1405163518 320 $aIncludes bibliographical references and index. 327 $aAntiarrhythmic Drugs; Contents; Preface; Acknowledgments; Part 1 Basic principles; Chapter 1 Mechanisms of cardiac tachyarrhythmias; Chapter 2 Introduction to antiarrhythmic drugs; Part 2 Clinical features of antiarrhythmic drugs; Chapter 3 Class I antiarrhythmic drugs; Chapter 4 Class II antiarrhythmic drugs; beta-blocking agents; Chapter 5 Class III antiarrhythmic drugs; Chapter 6 Class IV drugs: calcium-blocking agents; Chapter 7 Unclassified antiarrhythmic agents; Chapter 8 Investigational antiarrhythmic drugs; Chapter 9 Common adverse events with antiarrhythmic drugs 327 $aPart 3 Antiarrhythmic drugs in the treatment of cardiac arrhythmias Chapter 10 Basic principles of using antiarrhythmic drugs; Chapter 11 Treatment of supraventricular tachyarrhythmias; Chapter 12 Treatment of ventricular arrhythmias; Chapter 13 Treatment of arrhythmias in pregnancy; Index 330 $aIf you prescribe for patients with arrhythmias, you will want to keep this valuable paperback close at hand. The Second Edition of this valuable reference responds to changes in the available medications as well as in the way they are currently used. The book reviews everything you need to understand and prescribe today's antiarrhythmic drugs: mechanisms of cardiac arrhythmias and how antiarrhythmic drugs alter those arrhythmias, including common adverse effects which factors to consider in using these drugs for treatment of supraventricular tachyarrh 606 $aMyocardial depressants 606 $aInternal medicine 615 0$aMyocardial depressants. 615 0$aInternal medicine. 676 $a615.716 700 $aFogoros$b Richard N$0854280 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019464703321 996 $aAntiarrhythmic drugs$92230651 997 $aUNINA